---
figid: PMC5267352__nihms842841f1
figlink: /pmc/articles/PMC5267352/figure/F1/
number: F1
caption: Natural and synthetic Nrf2 activators induce structural changes in Keap1
  protein that compromises its ability to retain Nrf2 in the cytoplasm. This allows
  nuclear translocation of Nrf2 where it binds to antioxidant response elements (AREs)
  to initiate transcription of multiple target genes (Gstm1, HO-1, Catalase, Entpd5,
  G6pdx, Pdg, Tkt, Nqo1 etc.) important for antioxidant, xenobiotic and homeostatic
  responses. Targeting these Nrf2 responses could provide significant protection and
  therapy in kidney diseases including acute kidney injury, chronic kidney disease,
  polycystic kidney disease, diabetic nephropathy, hypertension, glomerulonephritis,
  renal cancer and hydronephrosis.
pmcid: PMC5267352
papertitle: Reviving the promise of transcription factor Nrf2 based therapeutics for
  kidney diseases.
reftext: Sanjeev Noel, et al. Kidney Int. 2015 Dec;88(6):1217-1218.
pmc_ranked_result_index: '12272'
pathway_score: 0.8052062
filename: nihms842841f1.jpg
figtitle: Reviving the promise of transcription factor Nrf2 based therapeutics for
  kidney diseases
year: '2015'
organisms:
- Mus musculus
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5267352__nihms842841f1.html
  '@type': Dataset
  description: Natural and synthetic Nrf2 activators induce structural changes in
    Keap1 protein that compromises its ability to retain Nrf2 in the cytoplasm. This
    allows nuclear translocation of Nrf2 where it binds to antioxidant response elements
    (AREs) to initiate transcription of multiple target genes (Gstm1, HO-1, Catalase,
    Entpd5, G6pdx, Pdg, Tkt, Nqo1 etc.) important for antioxidant, xenobiotic and
    homeostatic responses. Targeting these Nrf2 responses could provide significant
    protection and therapy in kidney diseases including acute kidney injury, chronic
    kidney disease, polycystic kidney disease, diabetic nephropathy, hypertension,
    glomerulonephritis, renal cancer and hydronephrosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NQO1
  - ENTPD5
  - KEAP1
  - TKT
  - GSTM1
  - PHGDH
  - sulforaphane
  - CDDO-Me (bardoxolone)
  - CDDO-Im
  - oleanolic acid
  - chalcones
genes:
- word: Nqo1
  symbol: NQO1
  source: hgnc_symbol
  hgnc_symbol: NQO1
  entrez: '1728'
- word: Entpd5
  symbol: ENTPD5
  source: hgnc_symbol
  hgnc_symbol: ENTPD5
  entrez: '957'
- word: Keap1
  symbol: KEAP1
  source: hgnc_symbol
  hgnc_symbol: KEAP1
  entrez: '9817'
- word: Tkt
  symbol: TKT
  source: hgnc_symbol
  hgnc_symbol: TKT
  entrez: '7086'
- word: Gstm1
  symbol: GSTM1
  source: hgnc_symbol
  hgnc_symbol: GSTM1
  entrez: '2944'
- word: Pdg
  symbol: PDG
  source: hgnc_alias_symbol
  hgnc_symbol: PHGDH
  entrez: '26227'
chemicals:
- word: sulforaphane
  source: MESH
  identifier: C016766
- word: CDDO-Me (bardoxolone)
  source: MESH
  identifier: C445068
- word: CDDO-Im
  source: MESH
  identifier: C472829
- word: oleanolic acid
  source: MESH
  identifier: D009828
- word: chalcones
  source: MESH
  identifier: D047188
diseases: []
figid_alias: PMC5267352__F1
redirect_from: /figures/PMC5267352__F1
figtype: Figure
---
